{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:20:26Z","timestamp":1790713226232,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s00066-009-1986-8","type":"journal-article","created":{"date-parts":[[2009,12,14]],"date-time":"2009-12-14T01:07:27Z","timestamp":1260752847000},"page":"799-807","source":"Crossref","is-referenced-by-count":54,"title":["Intensity-Modulated Arc Therapy with Simultaneous Integrated Boost in the Treatment of Primary Irresectable Cervical Cancer","Intensit\u00e4tsmodulierte Radiotherapie mit simultanem integriertem Boost zur prim\u00e4ren Behandlung des inoperablen Zervixkarzinoms. Planung, Qualit\u00e4tssicherung und klinische Umsetzung"],"prefix":"10.1007","volume":"185","author":[{"given":"Katrien","family":"Vandecasteele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"De Neve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"De Gersem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louke","family":"Delrue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Paelinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Makar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Fonteyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"De Wagter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Villeirs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"De Meerleer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,15]]},"reference":[{"key":"1986_CR1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ejso.2007.04.006","volume":"34","author":"X. Carcopino","year":"2008","unstructured":"Carcopino X, Houvenaeghel G, Buttarelli M, et al. Equivalent survival in patients with advanced stage IB\u2013II and III\u2013IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy. Eur J Surg Oncol 2008;34:569\u2013575.","journal-title":"Eur J Surg Oncol"},{"key":"1986_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1748-717X-1-13","volume":"1","author":"P. Chan","year":"2006","unstructured":"Chan P, Yeo I, Perkins G, et al. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study. Radiat Oncol 2006;1:13.","journal-title":"Radiat Oncol"},{"key":"1986_CR3","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ijrobp.2006.11.005","volume":"67","author":"M.F. Chen","year":"2007","unstructured":"Chen MF, Tseng CJ, Tseng CC, et al. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1438\u20131444.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1986_CR4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/gyno.1993.1132","volume":"49","author":"D. Choy","year":"1993","unstructured":"Choy D, Wong LC, Sham J, et al. Dose-tumor response of carcinoma of cervix: an analysis of 594 patients treated by radiotherapy. Gynecol Oncol 1993;49:311\u2013317.","journal-title":"Gynecol Oncol"},{"key":"1986_CR5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ygyno.2006.01.022","volume":"102","author":"J.M. Classe","year":"2006","unstructured":"Classe JM, Rauch P, Rodier JF, et al. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer). Gynecol Oncol 2006;102:523\u2013529.","journal-title":"Gynecol Oncol"},{"key":"1986_CR6","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0360-3016(01)02607-4","volume":"51","author":"W. Gersem De","year":"2001","unstructured":"De Gersem W, Claus F, De Wagter C, et al. Leaf position optimization for step-and-shoot IMRT. Int J Radiat Oncol Biol Phys 2001;51:1371\u20131388.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl1","key":"1986_CR7","doi-asserted-by":"crossref","first-page":"32s","DOI":"10.1016\/S1278-3218(02)00216-0","volume":"6","author":"W. Neve de","year":"2002","unstructured":"de Neve W, Duthoy W, Claus F, et al. Dose conformation in IMRT for head and neck tumors: which solution to apply? Cancer Radiother 2002;6:Suppl 1:32s\u201336s.","journal-title":"Cancer Radiother"},{"key":"1986_CR8","first-page":"117","volume-title":"Image-guided IMRT","author":"C. Wagter De","year":"2005","unstructured":"De Wagter C. QA-QC of IMRT: European perspective. In: Bortfeld T, Schmidt-Ullrich R, De Neve W, et al., eds. Image-guided IMRT. Berlin: Springer, 2005:117\u2013128."},{"key":"1986_CR9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00066-009-1918-7","volume":"185","author":"J.C. Dimopoulos","year":"2009","unstructured":"Dimopoulos JC, Schirl G, Baldinger A, et al. MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol 2009;185:282\u2013287.","journal-title":"Strahlenther Onkol"},{"key":"1986_CR10","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.ijrobp.2004.07.721","volume":"61","author":"W.D. D\u2019souza","year":"2005","unstructured":"D\u2019souza WD, Ahamad AA, Iyer RB, et al. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys 2005;61:1062\u20131070.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1986_CR11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0360-3016(03)00663-1","volume":"57","author":"W. Duthoy","year":"2003","unstructured":"Duthoy W, De Gersem W, Vergote K, et al. Whole abdominopelvic radiotherapy (WAPRT) using intensity-modulated arc therapy (IMAT): first clinical experience. Int J Radiat Oncol Biol Phys 2003;57:1019\u20131032.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1986_CR12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2004.04.016","volume":"60","author":"W. Duthoy","year":"2004","unstructured":"Duthoy W, De Gersem W, Vergote K, et al. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys 2004;60:794\u2013806.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1986_CR13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","volume":"21","author":"B. Emami","year":"1991","unstructured":"Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109\u2013122.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1986_CR14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.radonc.2007.06.013","volume":"84","author":"V. Fonteyne","year":"2007","unstructured":"Fonteyne V, De Neve W, Villeirs G, et al. Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity. Radiother Oncol 2007;84:156\u2013163.","journal-title":"Radiother Oncol"},{"key":"1986_CR15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00066-008-1872-9","volume":"184","author":"D. Georg","year":"2008","unstructured":"Georg D, Georg P, Hillbrand M, et al. Assessment of improved organ at risk sparing for advanced cervix carcinoma utilizing precision radiotherapy techniques. Strahlenther Onkol 2008;184:586\u2013591.","journal-title":"Strahlenther Onkol"},{"key":"1986_CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00066-007-2008-3","volume":"183","author":"D. Georg","year":"2007","unstructured":"Georg D, Kirisits C, Hillbrand M, et al. Preliminary results of a comparison between high-tech external beam and high-tech brachytherapy for cervix carcinoma. Strahlenther Onkol 2007;183:Special Issue 2:19\u201320.","journal-title":"Strahlenther Onkol"},{"key":"1986_CR17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ygyno.2005.12.044","volume":"102","author":"K. Gerszten","year":"2006","unstructured":"Gerszten K, Colonello K, Heron DE, et al. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecol Oncol 2006;102:182\u2013188.","journal-title":"Gynecol Oncol"},{"key":"1986_CR18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.radonc.2005.06.021","volume":"76","author":"S. Gillis","year":"2005","unstructured":"Gillis S, De Wagter C, Bohsung J, et al. An inter-centre quality assurance network for IMRT verification: results of the ESTRO QUASIMODO project. Radiother Oncol 2005;76:340\u2013353.","journal-title":"Radiother Oncol"},{"key":"1986_CR19","first-page":"CD002225","volume":"3","author":"J. Green","year":"2005","unstructured":"Green J, Kirwan J, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2005;3:CD002225.","journal-title":"Cochrane Database Syst Rev"},{"key":"1986_CR20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00066-005-1422-7","volume":"181","author":"A.L. Grosu","year":"2005","unstructured":"Grosu AL, Piert M, Weber WA, et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 2005;181:483\u2013499.","journal-title":"Strahlenther Onkol"},{"key":"1986_CR21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ijrobp.2004.11.040","volume":"62","author":"M. Guerrero","year":"2005","unstructured":"Guerrero M, Li XA, Ma L, et al. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations. Int J Radiat Oncol Biol Phys 2005;62:933\u2013939.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1986_CR22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ejso.2006.10.011","volume":"33","author":"G. Houvenaeghel","year":"2007","unstructured":"Houvenaeghel G, Lelievre L, Buttarelli M, et al. Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma. Eur J Surg Oncol 2007;33:498\u2013503.","journal-title":"Eur J Surg Oncol"},{"key":"1986_CR23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/srao.2002.32471","volume":"12","author":"B.D. Kavanagh","year":"2002","unstructured":"Kavanagh BD, Schefter TE, Wu Q, et al. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 2002;12:260\u2013271.","journal-title":"Semin Radiat Oncol"},{"key":"1986_CR24","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","volume":"340","author":"H.M. Keys","year":"1999","unstructured":"Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154\u20131161.","journal-title":"N Engl J Med"},{"key":"1986_CR25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0090-8258(03)00173-2","volume":"89","author":"H.M. Keys","year":"2003","unstructured":"Keys HM, Bundy BN, Stehman FB, et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol 2003;89:343\u2013353.","journal-title":"Gynecol Oncol"},{"key":"1986_CR26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clon.2005.09.001","volume":"18","author":"M. King","year":"2006","unstructured":"King M, McConkey C, Latief TN, et al. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects. Clin Oncol (R Coll Radiol) 2006;18:38\u201345.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1986_CR27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0167-8140(03)00197-X","volume":"68","author":"J.M. Kirwan","year":"2003","unstructured":"Kirwan JM, Symonds P, Green JA, et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003;68:217\u2013226.","journal-title":"Radiother Oncol"},{"key":"1986_CR28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0360-3016(91)90143-R","volume":"20","author":"R.M. Lanciano","year":"1991","unstructured":"Lanciano RM, Martz K, Coia LR, et al. Tumor and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat Oncol Biol Phys 1991;20:95\u2013100.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1986_CR29","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1118\/1.598248","volume":"25","author":"D.A. Low","year":"1998","unstructured":"Low DA, Harms WB, Mutic S, et al. A technique for the quantitative evaluation of dose distributions. Med Phys 1998;25:656\u2013661.","journal-title":"Med Phys"},{"key":"1986_CR30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/clon.2002.0076","volume":"14","author":"H. Lukka","year":"2002","unstructured":"Lukka H, Hirte H, Fyles A, et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer \u2014 a meta-analysis. Clin Oncol (R Coll Radiol) 2002;14:203\u2013212.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1986_CR31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0305-7372(03)00117-8","volume":"29","author":"J.H. Maduro","year":"2003","unstructured":"Maduro JH, Pras E, Willemse PH, et al. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev 2003;29:471\u2013488.","journal-title":"Cancer Treat Rev"},{"key":"1986_CR32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/gyno.2000.5862","volume":"78","author":"S. Mancuso","year":"2000","unstructured":"Mancuso S, Smaniotto D, Benedetti Panici P, et al. Phase I\u2013II trial of preoperative chemoradiation in locally advanced cervical carcinoma. Gynecol Oncol 2000;78:324\u2013328.","journal-title":"Gynecol Oncol"},{"key":"1986_CR33","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0360-3016(94)00431-J","volume":"31","author":"L.B. Marks","year":"1995","unstructured":"Marks LB, Carroll PR, Dugan TC, et al. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 1995;31:1257\u20131280.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1986_CR34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","volume":"340","author":"M. Morris","year":"1999","unstructured":"Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137\u20131143.","journal-title":"N Engl J Med"},{"key":"1986_CR35","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0360-3016(01)02785-7","volume":"52","author":"A.J. Mundt","year":"2002","unstructured":"Mundt AJ, Lujan AE, Rotmensch J, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002;52:1330\u20131337.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1986_CR36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00066-009-1893-z","volume":"185","author":"V. Nagy","year":"2009","unstructured":"Nagy V, Coza O, Ordeanu C, et al. Radiotherapy versus concurrent 5-day cisplatin and radiotherapy in locally advanced cervical carcinoma. Long-term results of a phase III randomized trial. Strahlenther Onkol 2009;185:177\u2013183.","journal-title":"Strahlenther Onkol"},{"key":"1986_CR37","first-page":"47","volume":"27","author":"Y. Niibe","year":"2006","unstructured":"Niibe Y, Hayakawa K, Kanai T, et al. Optimal dose for stage IIIB adenocarcinoma of the uterine cervix on the basis of biological effective dose. Eur J Gynaecol Oncol 2006;27:47\u201349.","journal-title":"Eur J Gynaecol Oncol"},{"key":"1986_CR38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1088\/0031-9155\/52\/1\/015","volume":"52","author":"L. Paelinck","year":"2007","unstructured":"Paelinck L, De Neve W, De Wagter C. Precautions and strategies in using a commercial flatbed scanner for radiochromic film dosimetry. Phys Med Biol 2007;52:231\u2013242.","journal-title":"Phys Med Biol"},{"key":"1986_CR39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/gyno.1999.5691","volume":"76","author":"P.J. Paley","year":"2000","unstructured":"Paley PJ, Goff BA, Minudri R, et al. The prognostic significance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical carcinoma. Gynecol Oncol 2000;76:373\u2013379.","journal-title":"Gynecol Oncol"},{"key":"1986_CR40","first-page":"1842","volume":"46","author":"N. Pandit-Taskar","year":"2005","unstructured":"Pandit-Taskar N. Oncologic imaging in gynecologic malignancies. J Nucl Med 2005;46:1842\u20131850.","journal-title":"J Nucl Med"},{"key":"1986_CR41","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","volume":"18","author":"W.A. Peters 3rd","year":"2000","unstructured":"Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606\u20131613.","journal-title":"J Clin Oncol"},{"key":"1986_CR42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0360-3016(01)01664-9","volume":"51","author":"L. Portelance","year":"2001","unstructured":"Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001;51:261\u2013266.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1986_CR43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2007.04.012","volume":"83","author":"R. Potter","year":"2007","unstructured":"Potter R, Dimopoulos J, Georg P, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007;83:148\u2013155.","journal-title":"Radiother Oncol"},{"key":"1986_CR44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1006\/gyno.1994.1168","volume":"54","author":"M. Resbeut","year":"1994","unstructured":"Resbeut M, Cowen D, Viens P, et al. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. Gynecol Oncol 1994;54:68\u201375.","journal-title":"Gynecol Oncol"},{"key":"1986_CR45","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1200\/JCO.2006.09.4532","volume":"25","author":"P.G. Rose","year":"2007","unstructured":"Rose PG, Ali S, Watkins E, et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007;25:2804\u20132810.","journal-title":"J Clin Oncol"},{"key":"1986_CR46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ajog.2007.08.003","volume":"197","author":"F.B. Stehman","year":"2007","unstructured":"Stehman FB, Ali S, Keys HM, et al. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol 2007;197:503 e1\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"1986_CR47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00066-007-1732-z","volume":"183","author":"F. Sterzing","year":"2007","unstructured":"Sterzing F, Grehn C, Dinkel J, et al. Severe reversible toxic encephalopathy induced by cisplatin in a patient with cervical carcinoma receiving combined radiochemotherapy. Strahlenther Onkol 2007;183:487\u2013489.","journal-title":"Strahlenther Onkol"},{"key":"1986_CR48","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ijrobp.2005.05.062","volume":"63","author":"A. Taylor","year":"2005","unstructured":"Taylor A, Rockall AG, Reznek RH, et al. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005;63:1604\u20131612.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1986_CR49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1088\/0031-9155\/49\/2\/008","volume":"49","author":"K. Vergote","year":"2004","unstructured":"Vergote K, De Deene Y, Duthoy W, et al. Validation and application of polymer gel dosimetry for the dose verification of an intensity-modulated arc therapy (IMAT) treatment. Phys Med Biol 2004;49:287\u2013305.","journal-title":"Phys Med Biol"},{"key":"1986_CR50","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00066-005-1383-x","volume":"181","author":"G.M. Villeirs","year":"2005","unstructured":"Villeirs GM, Van Vaerenbergh K, Vakaet L, et al. Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer. Strahlenther Onkol 2005;181:424\u2013430.","journal-title":"Strahlenther Onkol"},{"key":"1986_CR51","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00066-008-1814-6","volume":"184","author":"H. Vorwerk","year":"2008","unstructured":"Vorwerk H, Wagner D, Christiansen H, et al. An easy irradiation technique (partial half-beam) to reduce renal dose in radiotherapy of cervical cancer including paraaortic lymph nodes. Strahlenther Onkol 2008;184:473\u2013477.","journal-title":"Strahlenther Onkol"},{"key":"1986_CR52","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","volume":"17","author":"C.W. Whitney","year":"1999","unstructured":"Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339\u20131348.","journal-title":"J Clin Oncol"},{"key":"1986_CR53","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ijrobp.2004.06.253","volume":"61","author":"E. Wong","year":"2005","unstructured":"Wong E, D\u2019souza DP, Chen JZ, et al. Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies. Int J Radiat Oncol Biol Phys 2005;61:830\u2013841.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-1986-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-009-1986-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-1986-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:30:54Z","timestamp":1558564254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-009-1986-8"}},"subtitle":["Treatment Planning, Quality Control, and Clinical Implementation"],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["1986"],"URL":"https:\/\/doi.org\/10.1007\/s00066-009-1986-8","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}